Tmem63c is often a prospective prosurvival factor in angiotensin IItreated human podocytes: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 January 2024

  • curprev 22:3122:31, 21 January 2024‎ Chilltomato3 talk contribs‎ 3,783 bytes +3,783‎ Created page with "NCT02244632, very first published about ClinicalTrials.gov about Sept Twenty, 2014.NCT02244632, 1st put up on ClinicalTrials.gov on September 19, This year. Chemotherapy-induced nausea and vomiting (CINV) can result in a substantial damage from the standard of living of cancer malignancy individuals receiving radiation treatment. This study aimed to ascertain whether or not ABCB1 2677G > T/A had been linked to full reply (CR; understood to be simply no nausea with..."
Retrieved from "https://news.npo.digital/index.php?title=Tmem63c_is_often_a_prospective_prosurvival_factor_in_angiotensin_IItreated_human_podocytes"